Decoy Therapeutics Inc. (DCOY) income statement
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.88−0.07 (-7.31%)
Close on Nov 18, 2026Market cap $576.56KP/E –Yield –
Decoy Therapeutics Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -338.3%
Financial strength
- Current ratio
- 1.83
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 177.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.13
- Dividend yield
- –
See a number that looks wrong?